Pancreatic cancer is cancer that starts in the pancreas. The pancreas makes enzymes and hormones vital for promoting digestion and regulating blood sugar. Specific biomarkers, called tumor markers, ...
Cancer is a heterogeneous but related group of diseases wherein cells in certain tissues of the body proliferate uncontrollably and eventually invade adjacent and distant tissues. The oldest known ...
Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer Although ...
A cancer survivor describes the emotional rollercoaster of learning her tumor marker levels have risen. "I had decided that this would be the year I would bid farewell to my cancer journey. So much ...
Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...
Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel tumor ...
Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...
Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial A total of 302 patients ...
A clinical trial conducted by the University of Maryland School of Medicine showed that using focused ultrasound to open the blood-brain barrier before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results